- Subject requires any medical intervention(s) or has any other condition(s) that, in the Investigator's opinion, will 1) make the administration of PROSTVAC-V/F or ipilimumab hazardous, 2) obscure the interpretation of AEs, 3) compromise adherence with study requirements, or 4) otherwise compromise the study's objectives.